Modulation of Mitochondrial Permeability Transition Pore Affects Multidrug Resistance in Human Hepatocellular Carcinoma Cells

International Journal of Biological Sciences

Volumn 6, Issue 7, 2010, Pages 773-783

  Ling, Xianlong ^a   Zhou, Yuan ^a   Li, Shi Wei ^a   Yan, Bin ^a   Wen, Lei ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Mitochondrial membrane potential; Mitochondrial permeability transition pore; Multidrug resistance

Indexed keywords

EID: 78650556966     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.6.773     Document Type: Article

References (28)

1. Thun MJ, De Lancey JO, Center MM, et al. The global burden of cancer: priorities for prevention. Carcinogenesis.2010;31:100-10.
2. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132: 2557-76.
3. Okuda K. Hepatocellular carcinoma. J Hepatol.2000;32:225-37.
4. Wakamatsu T, Nakahashi Y, Hachimine D, et al. The combination of glycyrrhizin and lamivudine can reverse the cisplatin resistance in hepatocellular carcinoma cells through inhibition of multidrug resistance-associated proteins. Int J Oncol. 2007;31:1465-72.
5. Folmer Y, Schneider M, Blum HE, et al. Reversal of drug resistance of hepatocellular carcinoma cells by adenoviral delivery of anti-ABCC2 antisense constructs. Cancer Gene Ther.2007;14:875-84.
6. Pérez-Tomás R. Multidrug resistance: retrospect and prospects in anti-cancer drug treatment. Curr Med Chem.2006; 13: 1859-76.
7. Galluzzi L, Larochette N, Zamzami N, et al. Mitochondria as therapeutic targets for cancer chemotherapy. Oncogene. 2006;25:4812-30
8. Zhou Y, Ling XL, Li SW, et al. Establishment of a human hepatoma multidrug resistant cell line in vitro. World J Gastroenterol. 2010;16(18):2291-7.
9. Solazzo M, Fantappiè O, Lasagna N, et al. P-gp localization in mitochondria and its functional characterization in multiple drug-resistant cell lines. Experimental Cell Research.2006; 312:4070-8.
10. Scala S, Pacelli R, Iaffaioli RV, et al. Reversal of adriamycin resistance by recombinant alpha-interferon in multidrug- resistant human colon carcinoma LoVo- doxorubicin cells. Cancer Res.1991;51: 4898-902.
11. Kang Y, Perry RR. Modulatory effects of tamoxifen and recombinant human alpha-interferon on doxorubicin resistance. Cancer Res.1993;53: 3040-5.
12. Chaudhary PM, Roninson IB. Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs. J Natl Cancer Inst.1993;85: 632-9
13. Takeuchi A, Kaneko S, Matsushita E, et al. Interferon-alpha modulates resistance to cisplatin in three human hepatoma cell lines. J Gastroenterol.1999;34: 351-8.
14. Kim H, Park C, Han KH, et al. Primary liver carcinoma of intermediate (hepatocyte-cholangiocyte) phenotype. J Hepatol. 2004;40: 298-304.
15. Lee JS, Heo J, Libbrecht L, et al. A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells. Nat Med.2006;12: 410-6
16. Liu FS. Mechanisms of chemotherapeutic drug resistance in cancer therapy - a quick review. Taiwan J Obstet Gynecol.2009; 48: 239-44.
17. Daood M, Tsai C, Ahdab-Barmada M, et al. ABC transporter (P-gp/ABCB1, MRP1/ABCC1, BCRP/ABCG2) expression in the developing human CNS. Neuropediatrics.2008; 39:211-8
18. Kojima H, Endo K, Moriyama H, et al. Abrogation of mitochondrial cytochrome c release and caspase-3 activation in acquired multidrug resistance. J Biol Chem.1998;273: 16647-50
19. Mantovani I, Cappellini A, Tazzari PL, et al. Caspase- dependent cleavage of 170-kDa P-glycoprotein during apoptosis of human T-lymphoblastoid CEM cells. J Cell Physiol. 2006;207: 836-44
20. Evseenko DA, Murthi P, Paxton JW, et al. The ABC transporter BCRP/ABCG2 is a placental survival factor, and its expression is reduced in idiopathic human fetal growth restriction. FASEB J. 2007; 21: 3592-605
21. Jana S, Paliwal J. Apoptosis: potential therapeutic targets for new drug discovery. Curr Med Chem.2007;14: 2369-79
22. Javadov S, Karmazyn M. Mitochondrial permeability transition pore opening as an endpoint to initiate cell death and as a putative target for cardioprotection. Cell Physiol Biochem.2007;20: 1-22
23. Grimm S, Brdiczka D. The permeability transition pore in cell death. Apoptosis.2007; 12: 841-55
24. Maraldi NM, Zini N, Santi S,et al. P-glycoprotein subcellular localization and cell morphotype in MDR1 gene-transfected human osteosarcoma cells. Biol. Cell.1999;91:17-28.
25. Molinari A, Cianfriglia M, Meschini S, et al. P-glycoprotein expression in the Golgi apparatus of multidrug-resistant cells. Int. J. Cancer.1994;59: 789-95.
26. Croop JM, Guild BC, Gros P, et al. Genetics of multidrug resistance: relationship of a cloned gene to the complete multidrug resistant phenotype. Cancer Res.1987;47: 5982-8.
27. Munteanu E, Verdier M, Forestier FG, et al. Mitochondrial localization and activity of P-glycoprotein in doxorubicin- resistant K562 cells. Biochem. Pharmaco. 2006; 71: 1162-74
28. Mantovani I, Cappellini A, Tazzari PL, et al. Caspase-dependent cleavage of 170-kDa P-glycoprotein during apoptosis of human T-lymphoblastoid CEM cells. J. Cell. Physiol. 2006; 207: 836-44.